145 related articles for article (PubMed ID: 10227750)
21. Introduction of new technologies for the treatment of diabetic complications: cryoreactive albumin removal apheresis.
Nosé Y; Ohta K; Suki WN; Takaba J; Miyamoto H
Artif Organs; 2011 Jan; 35(1):4-8. PubMed ID: 21226744
[No Abstract] [Full Text] [Related]
22. Apheresis technologies and clinical applications: the 2000 International Apheresis Registry.
Malchesky PS; Koo AP; Rybicki LA
Ther Apher; 2001 Jun; 5(3):193-206. PubMed ID: 11467756
[TBL] [Abstract][Full Text] [Related]
23. Spin doctors: new innovations for centrifugal apheresis.
Kambic HE; Nosé Y
Ther Apher; 1997 Aug; 1(3):284-305. PubMed ID: 10225752
[TBL] [Abstract][Full Text] [Related]
24. Design of a plasma separator using ceramic membranes.
Sakurai H; Ozawa K; Takesawa S; Sakai K
ASAIO Trans; 1986; 32(1):410-3. PubMed ID: 3778744
[No Abstract] [Full Text] [Related]
25. Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.
Tormey CA; Peddinghaus ME; Erickson M; King KE; Cushing MM; Bill J; Goodrich T; Snyder EL
Transfusion; 2010 Feb; 50(2):471-7. PubMed ID: 19804570
[TBL] [Abstract][Full Text] [Related]
26. High efficiency of CD34+ selection by removal of platelets from the apheresis product.
Schreiner T; Maccari B; Erne E; Bischof C; Wiesneth M
Beitr Infusionsther Transfusionsmed; 1997; 34():144-9. PubMed ID: 9356665
[No Abstract] [Full Text] [Related]
27. Application of an automated plasma filtration device and a blood monitoring system for LDL apheresis.
Taborski U; Köhler T; Schüpphaus S; Hofmann MR; Müller-Berghaus G
Infusionsther Transfusionsmed; 1992 Aug; 19(4):187-9. PubMed ID: 1422076
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Fractionation Membranes in an Animal Model of Double Filtration Lipoprotein Apheresis.
Krieter DH; Lange F; Lemke HD; Bonn F; Wanner C
Ther Apher Dial; 2018 Apr; 22(2):189-195. PubMed ID: 29316258
[TBL] [Abstract][Full Text] [Related]
29. Ash Split Catheter for vascular access in apheresis.
Ash SR
Ther Apher Dial; 2003 Apr; 7(2):150-2. PubMed ID: 12918935
[No Abstract] [Full Text] [Related]
30. Therapeutic apheresis.
Purandare L
Prof Nurse; 1994 Jun; 9(9):626-31. PubMed ID: 8058811
[TBL] [Abstract][Full Text] [Related]
31. A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis.
Ghio M; Contini P; Ansaldi F; Ubezio G; Setti M; Risso M; Tripodi G
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s167-9. PubMed ID: 23736914
[No Abstract] [Full Text] [Related]
32. Status of therapeutic apheresis in Europe.
Gurland HJ
J Clin Apher; 1991; 6(2):93-4. PubMed ID: 1938997
[TBL] [Abstract][Full Text] [Related]
33. Comparison of plasma exchange performances between Spectra Optia and COBE Spectra apheresis systems in repeated procedures considering variability and using specific statistical models.
Hequet O; Stocco V; Assari S; Drillat P; Le QH; Kassir A; Rigal D; Bouzgarrou R
Transfus Apher Sci; 2014 Aug; 51(1):47-53. PubMed ID: 25130725
[TBL] [Abstract][Full Text] [Related]
34. Plasma separation using a hollow fiber membrane device.
Buchholz DH; Lin A; Snyder E; McCullough J; Porten J; Anderson M; Smith J; Dalmasso A; Helphingstine C; Path M
Transfusion; 1986; 26(2):145-50. PubMed ID: 3952789
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Plasma Exchange Using Membrane Plasma Separation.
Ahmed S; Kaplan A
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1364-1370. PubMed ID: 32312791
[TBL] [Abstract][Full Text] [Related]
36. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients.
Baricchi R; Pizzala R; Cacciavillani G; Rivasi P; Tomasi A
Ther Apher; 1998 Aug; 2(3):218-23. PubMed ID: 10227773
[TBL] [Abstract][Full Text] [Related]
37. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
38. The selective therapeutic apheresis procedures.
Sanchez AP; Cunard R; Ward DM
J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel membrane apheresis system for plasma collection at mobile sites.
Stromberg RR; Lysaght MJ; Boggs DR; Cole ML; Gritsman HN; Ritger PL; Wolf L; Friedman L
ASAIO Trans; 1987; 33(3):614-20. PubMed ID: 3675996
[No Abstract] [Full Text] [Related]
40. The French approach to donor apheresis guidelines.
Calot JP
Transfus Sci; 1990; 11(3-4):319-22. PubMed ID: 10149533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
